US Stock MarketDetailed Quotes

SFOSF SHANGHAI FOSUN PHARMACEUTICAL GROUP

Watchlist
  • 1.699
  • 0.0000.00%
15min DelayTrading Jan 3 16:00 ET
4.54BMarket Cap15.73P/E (TTM)

SHANGHAI FOSUN PHARMACEUTICAL GROUP Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
12.30%10.45B
-2.08%10.31B
-6.56%10.16B
-5.81%41.4B
-13.22%10.7B
-9.44%9.3B
-4.00%10.52B
4.68%10.87B
12.66%43.95B
3.06%12.33B
Operating revenue
12.30%10.45B
-2.08%10.31B
-6.56%10.16B
-5.81%41.4B
-13.22%10.7B
-9.44%9.3B
-4.00%10.52B
4.68%10.87B
12.66%43.95B
3.06%12.33B
Cost of revenue
6.79%5.43B
-0.33%5.39B
-4.10%5.08B
-6.80%21.6B
-7.05%5.82B
-4.75%5.08B
-5.47%5.4B
-9.67%5.29B
14.53%23.17B
-5.10%6.26B
Gross profit
18.91%5.02B
-3.92%4.92B
-8.90%5.08B
-4.70%19.8B
-19.57%4.88B
-14.51%4.22B
-2.40%5.12B
23.28%5.58B
10.65%20.78B
13.08%6.07B
Operating expense
-2.53%4.16B
-12.36%4.12B
-8.85%4.08B
6.39%18.24B
-8.48%4.8B
0.05%4.26B
18.41%4.7B
21.97%4.48B
6.68%17.15B
7.95%5.24B
Selling and administrative expenses
0.45%6.6B
-131.48%-101.66M
-7.52%3.24B
3.79%7.37B
-49.59%-3.02B
7.88%6.57B
81.67%322.99M
22.60%3.51B
-4.16%7.1B
-44.60%-2.02B
-Selling and marketing expense
0.86%3.97B
-50.50%385.49M
-10.93%2.24B
1.35%6.2B
-169.73%-1.03B
2.74%3.93B
29.69%778.74M
21.59%2.52B
-6.85%6.12B
-5,379.23%-381.37M
-General and administrative expense
-0.16%2.63B
-6.89%-487.15M
1.13%1B
18.90%1.17B
-21.64%-1.99B
16.59%2.63B
-7.82%-455.76M
25.25%991.09M
16.78%988.06M
-16.71%-1.64B
Research and development costs
-22.97%786.3M
-11.43%1.03B
-14.38%829.57M
1.02%4.35B
-17.26%1.19B
-1.42%1.02B
14.54%1.17B
19.66%968.87M
12.11%4.3B
1.12%1.44B
-Depreciation and amortization
----
----
----
14.61%914.69M
----
----
----
----
23.30%798.06M
----
Other operating expenses
15.26%69.61M
1.74%71.78M
37.93%92.44M
19.08%271.26M
16.31%73.29M
49.27%60.39M
-0.47%70.55M
25.41%67.02M
-7.93%227.8M
-15.53%63.01M
Operating profit
2,247.23%866.29M
90.54%799.99M
-9.12%996.26M
-57.01%1.56B
-89.46%87.62M
-105.94%-40.34M
-67.11%419.85M
28.94%1.1B
34.21%3.64B
61.38%831.28M
Net non-operating interest income expense
-2.88%-317.45M
-37.92%-256.9M
-7.26%-280.22M
-40.52%-997.35M
27.04%-241.27M
-593.57%-308.55M
18.14%-186.27M
-144.12%-261.26M
-14.72%-709.76M
-46.83%-330.69M
Non-operating interest income
-3.59%90.74M
9.74%89.29M
10.60%99.67M
28.66%363.65M
16.14%98.03M
17.93%94.12M
27.93%81.37M
64.43%90.12M
20.93%282.63M
42.53%84.41M
Non-operating interest expense
4.08%358.33M
13.53%361.45M
22.14%348.09M
37.46%1.32B
42.28%377.16M
32.15%344.29M
37.81%318.37M
37.57%285.01M
17.18%963.81M
39.22%265.08M
Total other finance cost
-14.59%49.86M
69.92%-15.26M
-52.09%31.8M
26.49%36.16M
-125.24%-37.86M
142.85%58.38M
-184.34%-50.73M
246.41%66.37M
-4.32%28.59M
59.53%150.02M
Other net income (expense)
Special income (charges)
83.71%-35.4M
61.38%-47.4M
61.33%-10.09M
-63.06%-346.11M
108.97%20.08M
-302.52%-217.36M
-37.03%-122.73M
-324.19%-26.11M
76.91%-212.25M
65.31%-223.87M
-Less:Impairment of capital assets
-89.57%20.77M
-66.79%26.06M
-144.64%-5.89M
-19.36%219.74M
-139.78%-71.16M
947.29%199.24M
4.35%78.48M
2,158.02%13.18M
-67.17%272.49M
-69.34%178.9M
-Less:Other special charges
67.30%-1.8M
78.45%-282.84K
-185.51%-434.1K
95.57%-5.56M
-94.93%735.9K
96.03%-5.49M
30.69%-1.31M
173.65%507.68K
-914.61%-125.6M
78.03%14.5M
-Write off
-30.41%16.43M
-52.54%21.62M
32.24%16.41M
101.82%131.93M
65.26%50.34M
95.99%23.61M
180.38%45.56M
87.81%12.41M
-11.68%65.37M
-43.24%30.46M
Other non- operating income (expenses)
-67.86%-37.94M
-68.14%4.85M
93.06%-2.94M
47.81%-42.94M
-93.67%6.8M
-54.17%-22.6M
109.14%15.23M
-410.57%-42.38M
68.34%-82.27M
147.36%107.44M
Income before tax
79.02%1.14B
-28.17%912.78M
-26.46%1.02B
-28.63%3.26B
-102.32%-27.89M
-37.47%636.99M
-13.84%1.27B
57.80%1.38B
-24.30%4.57B
-12.58%1.2B
Income tax
504.10%171.58M
-56.06%149.27M
-14.16%232.2M
-41.06%369.5M
-1,850.21%-269.14M
-72.28%28.4M
27.85%339.73M
11.16%270.51M
-41.21%626.92M
-95.41%15.38M
Net income
59.19%968.79M
-17.99%763.51M
-29.44%786.22M
-26.66%2.9B
-79.69%241.25M
-33.58%608.58M
-23.00%930.97M
75.70%1.11B
-20.67%3.95B
14.08%1.19B
Net income continuous Operations
59.19%968.79M
-17.99%763.51M
-29.44%786.22M
-26.66%2.9B
-79.69%241.25M
-33.58%608.58M
-23.00%930.97M
75.70%1.11B
-20.67%3.95B
14.08%1.19B
Minority interest income
77.63%182.94M
5.68%148.45M
38.66%176.49M
134.84%508.8M
229.41%138.05M
550.58%102.99M
8.13%140.47M
-28.33%127.28M
-12.48%216.66M
13.02%-106.68M
Net income attributable to the parent company
55.43%785.84M
-22.19%615.06M
-38.22%609.73M
-36.04%2.39B
-92.03%103.2M
-43.85%505.59M
-26.75%790.5M
116.17%986.97M
-21.10%3.73B
11.22%1.29B
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
55.43%785.84M
-22.19%615.06M
-38.22%609.73M
-36.04%2.39B
-92.03%103.2M
-43.85%505.59M
-26.75%790.5M
116.17%986.97M
-21.10%3.73B
11.22%1.29B
Basic earnings per share
52.63%0.29
-23.33%0.23
-37.84%0.23
-37.76%0.89
-93.88%0.03
-44.12%0.19
-28.57%0.3
105.56%0.37
-22.70%1.43
6.52%0.49
Diluted earnings per share
61.11%0.29
-23.33%0.23
-37.84%0.23
-37.76%0.89
-93.88%0.03
-47.06%0.18
-28.57%0.3
105.56%0.37
-22.70%1.43
6.52%0.49
Dividend per share
-33.64%0.2785
0
0
-25.55%0.4197
0
0.4197
0
0
30.27%0.5637
0
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 12.30%10.45B-2.08%10.31B-6.56%10.16B-5.81%41.4B-13.22%10.7B-9.44%9.3B-4.00%10.52B4.68%10.87B12.66%43.95B3.06%12.33B
Operating revenue 12.30%10.45B-2.08%10.31B-6.56%10.16B-5.81%41.4B-13.22%10.7B-9.44%9.3B-4.00%10.52B4.68%10.87B12.66%43.95B3.06%12.33B
Cost of revenue 6.79%5.43B-0.33%5.39B-4.10%5.08B-6.80%21.6B-7.05%5.82B-4.75%5.08B-5.47%5.4B-9.67%5.29B14.53%23.17B-5.10%6.26B
Gross profit 18.91%5.02B-3.92%4.92B-8.90%5.08B-4.70%19.8B-19.57%4.88B-14.51%4.22B-2.40%5.12B23.28%5.58B10.65%20.78B13.08%6.07B
Operating expense -2.53%4.16B-12.36%4.12B-8.85%4.08B6.39%18.24B-8.48%4.8B0.05%4.26B18.41%4.7B21.97%4.48B6.68%17.15B7.95%5.24B
Selling and administrative expenses 0.45%6.6B-131.48%-101.66M-7.52%3.24B3.79%7.37B-49.59%-3.02B7.88%6.57B81.67%322.99M22.60%3.51B-4.16%7.1B-44.60%-2.02B
-Selling and marketing expense 0.86%3.97B-50.50%385.49M-10.93%2.24B1.35%6.2B-169.73%-1.03B2.74%3.93B29.69%778.74M21.59%2.52B-6.85%6.12B-5,379.23%-381.37M
-General and administrative expense -0.16%2.63B-6.89%-487.15M1.13%1B18.90%1.17B-21.64%-1.99B16.59%2.63B-7.82%-455.76M25.25%991.09M16.78%988.06M-16.71%-1.64B
Research and development costs -22.97%786.3M-11.43%1.03B-14.38%829.57M1.02%4.35B-17.26%1.19B-1.42%1.02B14.54%1.17B19.66%968.87M12.11%4.3B1.12%1.44B
-Depreciation and amortization ------------14.61%914.69M----------------23.30%798.06M----
Other operating expenses 15.26%69.61M1.74%71.78M37.93%92.44M19.08%271.26M16.31%73.29M49.27%60.39M-0.47%70.55M25.41%67.02M-7.93%227.8M-15.53%63.01M
Operating profit 2,247.23%866.29M90.54%799.99M-9.12%996.26M-57.01%1.56B-89.46%87.62M-105.94%-40.34M-67.11%419.85M28.94%1.1B34.21%3.64B61.38%831.28M
Net non-operating interest income expense -2.88%-317.45M-37.92%-256.9M-7.26%-280.22M-40.52%-997.35M27.04%-241.27M-593.57%-308.55M18.14%-186.27M-144.12%-261.26M-14.72%-709.76M-46.83%-330.69M
Non-operating interest income -3.59%90.74M9.74%89.29M10.60%99.67M28.66%363.65M16.14%98.03M17.93%94.12M27.93%81.37M64.43%90.12M20.93%282.63M42.53%84.41M
Non-operating interest expense 4.08%358.33M13.53%361.45M22.14%348.09M37.46%1.32B42.28%377.16M32.15%344.29M37.81%318.37M37.57%285.01M17.18%963.81M39.22%265.08M
Total other finance cost -14.59%49.86M69.92%-15.26M-52.09%31.8M26.49%36.16M-125.24%-37.86M142.85%58.38M-184.34%-50.73M246.41%66.37M-4.32%28.59M59.53%150.02M
Other net income (expense)
Special income (charges) 83.71%-35.4M61.38%-47.4M61.33%-10.09M-63.06%-346.11M108.97%20.08M-302.52%-217.36M-37.03%-122.73M-324.19%-26.11M76.91%-212.25M65.31%-223.87M
-Less:Impairment of capital assets -89.57%20.77M-66.79%26.06M-144.64%-5.89M-19.36%219.74M-139.78%-71.16M947.29%199.24M4.35%78.48M2,158.02%13.18M-67.17%272.49M-69.34%178.9M
-Less:Other special charges 67.30%-1.8M78.45%-282.84K-185.51%-434.1K95.57%-5.56M-94.93%735.9K96.03%-5.49M30.69%-1.31M173.65%507.68K-914.61%-125.6M78.03%14.5M
-Write off -30.41%16.43M-52.54%21.62M32.24%16.41M101.82%131.93M65.26%50.34M95.99%23.61M180.38%45.56M87.81%12.41M-11.68%65.37M-43.24%30.46M
Other non- operating income (expenses) -67.86%-37.94M-68.14%4.85M93.06%-2.94M47.81%-42.94M-93.67%6.8M-54.17%-22.6M109.14%15.23M-410.57%-42.38M68.34%-82.27M147.36%107.44M
Income before tax 79.02%1.14B-28.17%912.78M-26.46%1.02B-28.63%3.26B-102.32%-27.89M-37.47%636.99M-13.84%1.27B57.80%1.38B-24.30%4.57B-12.58%1.2B
Income tax 504.10%171.58M-56.06%149.27M-14.16%232.2M-41.06%369.5M-1,850.21%-269.14M-72.28%28.4M27.85%339.73M11.16%270.51M-41.21%626.92M-95.41%15.38M
Net income 59.19%968.79M-17.99%763.51M-29.44%786.22M-26.66%2.9B-79.69%241.25M-33.58%608.58M-23.00%930.97M75.70%1.11B-20.67%3.95B14.08%1.19B
Net income continuous Operations 59.19%968.79M-17.99%763.51M-29.44%786.22M-26.66%2.9B-79.69%241.25M-33.58%608.58M-23.00%930.97M75.70%1.11B-20.67%3.95B14.08%1.19B
Minority interest income 77.63%182.94M5.68%148.45M38.66%176.49M134.84%508.8M229.41%138.05M550.58%102.99M8.13%140.47M-28.33%127.28M-12.48%216.66M13.02%-106.68M
Net income attributable to the parent company 55.43%785.84M-22.19%615.06M-38.22%609.73M-36.04%2.39B-92.03%103.2M-43.85%505.59M-26.75%790.5M116.17%986.97M-21.10%3.73B11.22%1.29B
Preferred stock dividends
Other preferred stock dividends 0000000000
Net income attributable to common stockholders 55.43%785.84M-22.19%615.06M-38.22%609.73M-36.04%2.39B-92.03%103.2M-43.85%505.59M-26.75%790.5M116.17%986.97M-21.10%3.73B11.22%1.29B
Basic earnings per share 52.63%0.29-23.33%0.23-37.84%0.23-37.76%0.89-93.88%0.03-44.12%0.19-28.57%0.3105.56%0.37-22.70%1.436.52%0.49
Diluted earnings per share 61.11%0.29-23.33%0.23-37.84%0.23-37.76%0.89-93.88%0.03-47.06%0.18-28.57%0.3105.56%0.37-22.70%1.436.52%0.49
Dividend per share -33.64%0.278500-25.55%0.419700.41970030.27%0.56370
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
NVIDIA
NVDA
125.929
Salesforce
CRM
361.125
Apple
AAPL
238.850
4
Oracle
ORCL
163.460
5
Meta Platforms
META
679.550
Log In for the Full List
Unlock Now
Headlines
Will AI application stocks become the biggest winners? DeepSeek helps the popularization and MMF of AI applications, and these Concept stocks are expected to usher in a new round of explosion.
Jan 28 23:55
Is DeepSeek providing assistance? Apple rises nearly 2% to firmly hold the title of "Global Stock King". Analysts state that the company is expected to benefit from DeepSeek's technological breakthroughs.
Jan 28 22:37
U.S. stock early market | The three major Indexes surged, with the Nasdaq up over 1%, Technology giants generally rose, Apple increased nearly 3% again, and Amazon and Meta both reached new highs.
Jan 28 23:29
Not just technology stocks! Deutsche Bank: DeepSeek will impact the Federal Reserve, the USA economy, and will be Bearish for the dollar in the long term.
Jan 28 23:10
A comprehensive read | DeepSeek released a new model on New Year's Eve, is the revolution of multimodal unification coming?
Jan 28 17:26